A study comparing 3 months versus 6 months of adjuvant chemotherapy for stage III colon cancer did not show non-inferiority for the shorter treatment duration. The 3-year disease-free survival rate was 74.6% for the 3-month group and 75.5% for the 6-month group, with a difference of less than 1%.